Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Bajorin

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|June 1, 1995
Paclitaxel in germ cell cancerR J Motzer, T C Chou, L Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patientsP J Mencel, R J Motzer, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Metastatic germ cell tumors: modeling for response to chemotherapyD F Bajorin, M Mazumdar, M Meyers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogsP J Cozzi, D F Bajorin, W Tong, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumorsJ Vuky, J McCaffrey, M Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|June 1, 1995
Paclitaxel in germ cell cancerR J Motzer, T C Chou, L Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patientsP J Mencel, R J Motzer, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Metastatic germ cell tumors: modeling for response to chemotherapyD F Bajorin, M Mazumdar, M Meyers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogsP J Cozzi, D F Bajorin, W Tong, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumorsJ Vuky, J McCaffrey, M Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Pageof 10